Table 2 The rate of adverse effects by the groups
Adverse effect | Daily treatment group | Twice weekly group | Significance | ||
|---|---|---|---|---|---|
n | % | n | % | ||
Drowsiness | 10 | 52.6 | 4 | 26.7 | X2 = 0.12, df = 1, P = 0.1 |
Increased appetite | 6 | 31.6 | 2 | 10.3 | X2 = 0.2, df = 1, P = 0.2 |
Fatigue | 2 | 10.5 % | 2 | 10.3 | – |
Irritability | 2 | 10.5 % | 0 | – | – |
Headache | 2 | 10.5 % | 2 | 10.3 | – |
Nausea | 1 | 5.3 | 2 | 10.3 | – |
Slowness | 1 | 5.3 | 0 | – | – |
Abdominal pain | 1 | 5.3 | 1 | 6.7 | – |
Dizziness | 0 | – | 1 | 6.7 | – |
Drooling | 1 | 5.3 | 0 | – | – |
Decreased appetite | 0 | – | 0 | – | – |
Tremor | 0 | – | 0 | – | – |
Itches | 0 | – | 0 | – | – |
Convulsion | 0 | – | 0 | – | – |
Akathisia | 0 | – | 0 | – | – |
Dyskinesia | 0 | – | 0 | – | – |
Diurnal urinary incontinency | 0 | – | 0 | – | – |
Walking problem | 0 | – | 0 | – | – |
Diarrhea | 0 | – | 0 | – | – |
Vomiting | 0 | – | 0 | – | – |
Insomnia | 0 | – | 0 | – | – |
Swallowing difficulty | 0 | – | 0 | – | – |
Blurred vision | 0 | – | 0 | – | – |